![Jan Brinkman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Loopbaan van Jan Brinkman
Eerdere bekende functies van Jan Brinkman
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
NANOMIX CORPORATION | Directeur/Bestuurslid | 25-09-2014 | 23-02-2016 |
Opleiding van Jan Brinkman
Erasmus University Rotterdam | Doctorate Degree |
INSEAD | Masters Business Admin |
University of Florence | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 2 |
Nederland | 2 |
Frankrijk | 2 |
Operationeel
Doctorate Degree | 2 |
Director/Board Member | 1 |
Masters Business Admin | 1 |
Sectoraal
Consumer Services | 4 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Boston Therapeutics, Inc.
![]() Boston Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Boston Therapeutics, Inc. is a pharmaceutical company, which engages in the development, manufacture, and commercialization of novel compounds based on complex carbohydrate chemistry. Its products are designed to help manage blood sugar, treat pre-diabetes, and diabetes related pathologies. Its drug candidates comprises of BTI320, BTI-410, and IPOXYN. The company was founded by David Platt and Kenneth A. Tassey Jr. on August 24, 2009 and is headquartered in Lawrence, MA. | Health Technology |
- Beurs
- Insiders
- Jan Brinkman
- Ervaring